ATE377074T1 - Methode zur bereitstellung von dna sequenzen - Google Patents

Methode zur bereitstellung von dna sequenzen

Info

Publication number
ATE377074T1
ATE377074T1 AT97924928T AT97924928T ATE377074T1 AT E377074 T1 ATE377074 T1 AT E377074T1 AT 97924928 T AT97924928 T AT 97924928T AT 97924928 T AT97924928 T AT 97924928T AT E377074 T1 ATE377074 T1 AT E377074T1
Authority
AT
Austria
Prior art keywords
activity
interest
dna sequences
structural gene
hybrid
Prior art date
Application number
AT97924928T
Other languages
English (en)
Inventor
Henrik Dalboege
Boerge Diderichsen
Thomas Sandal
Sakari Kauppinen
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Application granted granted Critical
Publication of ATE377074T1 publication Critical patent/ATE377074T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/248—Xylanases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01008—Endo-1,4-beta-xylanase (3.2.1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01032—Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT97924928T 1996-05-10 1997-05-12 Methode zur bereitstellung von dna sequenzen ATE377074T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK56296 1996-05-10

Publications (1)

Publication Number Publication Date
ATE377074T1 true ATE377074T1 (de) 2007-11-15

Family

ID=8094949

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97924928T ATE377074T1 (de) 1996-05-10 1997-05-12 Methode zur bereitstellung von dna sequenzen

Country Status (7)

Country Link
US (1) US6270968B1 (de)
EP (1) EP0898618B1 (de)
AT (1) ATE377074T1 (de)
AU (1) AU3025597A (de)
DE (1) DE69738254T2 (de)
DK (1) DK0898618T3 (de)
WO (1) WO1997043409A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69836227T2 (de) * 1997-12-16 2007-08-23 Genencor International, Inc., Palo Alto Verfahren zur herstellung egiii-ähnlicher enzyme
US6921655B1 (en) 1998-10-23 2005-07-26 Meiji Seika Kaisha, Ltd. Endoglucanases and cellulase preparations containing the same
JP2000253885A (ja) * 1999-03-11 2000-09-19 Jcr Pharmaceuticals Co Ltd 任意プライマーpcrを用いるdna断片クローニング方法
US7977051B2 (en) 1999-04-10 2011-07-12 Danisco Us Inc. EGIII-like enzymes, DNA encoding such enzymes and methods for producing such enzymes
DE10001140C2 (de) * 2000-01-13 2003-06-12 Gsf Forschungszentrum Umwelt Oligonukleotide zur Amplifikation und zum Nachweis von bakteriellen Genen für extrazelluläre alkalische Metallopeptidasen (Apr), neutrale Metallopeptidasen (Npr) und Serinpeptidasen (Spr)
CN102766614A (zh) * 2003-12-03 2012-11-07 明治制果药业株式会社 内切葡聚糖酶stce和含有内切葡聚糖酶的纤维素酶配制品
ES2539955T3 (es) * 2003-12-08 2015-07-07 Meiji Seika Pharma Co., Ltd. Celulasa tolerante a los tensioactivos y procedimiento de modificación de la misma
EP1612267A1 (de) * 2004-07-02 2006-01-04 GBF Gesellschaft für Biotechnologische Forschung mbH Zellulasen aus Rumen
ES2458301T3 (es) * 2005-04-29 2014-04-30 Ab Enzymes Oy Celulasas mejoradas
US7741093B2 (en) 2005-04-29 2010-06-22 Ab Enzymes Oy Cellulases and their uses
BRPI0923225A2 (pt) 2008-12-02 2016-10-04 Chiralgen Ltd metodo para sintese de acidos nucleicos modificados no atomo de fosforo
EP3444343B1 (de) * 2008-12-23 2020-10-28 DuPont Nutrition Biosciences ApS Polypeptide
EP2451461A4 (de) 2009-07-06 2013-05-29 Ontorii Inc Neuartige nukleinsäure-prodrugs und verwendungsverfahren dafür
DK2620428T3 (da) 2010-09-24 2019-07-01 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
CN107365339A (zh) 2011-07-19 2017-11-21 波涛生命科学有限公司 合成官能化核酸的方法
SG11201500243WA (en) 2012-07-13 2015-04-29 Shin Nippon Biomedical Lab Ltd Chiral nucleic acid adjuvant
WO2014010250A1 (en) 2012-07-13 2014-01-16 Chiralgen, Ltd. Asymmetric auxiliary group
DK2872147T3 (da) 2012-07-13 2023-02-20 Wave Life Sciences Ltd Fremgangsmåde til fremstilling af kirale oligonukleotider
WO2015108046A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
EP3095461A4 (de) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chirales nukleinsäure-adjuvans mit immunitätsinduktionswirkung und immunitätsinduktionsaktivator
EP3095459A4 (de) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chirales nukleinsäureadjuvans mit antitumorwirkung und antitumormittel
EP3094728B1 (de) 2014-01-16 2022-03-09 Wave Life Sciences Ltd. Chirales design
CN108699543B (zh) 2015-12-18 2023-07-14 丹尼斯科美国公司 具有内切葡聚糖酶活性的多肽及其用途
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI903489A7 (fi) * 1988-11-11 1990-07-10 Medical Res Council Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
US5780225A (en) * 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
ES2068586T5 (es) * 1990-05-09 2004-12-01 Novozymes A/S Una preparacion de celulasa que comprende una enzima endoglucanasa.
DK115890D0 (da) * 1990-05-09 1990-05-09 Novo Nordisk As Enzym
MX9206979A (es) * 1991-12-04 1993-07-01 Novo Nordisk As Metodo de clonacion de proteinas en levaduras
US5364787A (en) * 1992-03-23 1994-11-15 Idaho Research Foundation Genes and enzymes involved in the microbial degradation of pentachlorophenol
KR100303619B1 (ko) * 1992-10-06 2001-11-22 피아 스타르 셀룰라제변이체
EP2431462A3 (de) * 1995-03-17 2012-05-23 Novozymes A/S Neue Endoglukanasen
EP0851938A1 (de) * 1995-09-22 1998-07-08 Terragen Diversity Inc. Verfahren zur isolierung von xylanase-gensequenzen von dns aus erde, zusammensetzungen verwendbar in diesem verfahren und die damit enthaltendemn zubereitungen

Also Published As

Publication number Publication date
EP0898618B1 (de) 2007-10-31
DE69738254T2 (de) 2008-08-14
US6270968B1 (en) 2001-08-07
WO1997043409A3 (en) 1998-02-26
WO1997043409A2 (en) 1997-11-20
EP0898618A2 (de) 1999-03-03
AU3025597A (en) 1997-12-05
DK0898618T3 (da) 2008-02-25
DE69738254D1 (de) 2007-12-13

Similar Documents

Publication Publication Date Title
DE69738254D1 (de) Methode zur bereitstellung von dna sequenzen
WO1998050554A3 (en) Enterococcus faecalis polynucleotides and polypeptides
PT979308E (pt) Metodo de preparacao de um padrao tipo de um transcrito genetico para diagnostico
MX9705961A (es) Polimerasa de adn termoestable, modificada.
WO2001009301A3 (en) Nucleic acids and polypeptides of invertebrate twik channels and methods of use
ATE400651T1 (de) Verwendung von grünem fluoreszenzprotein
GB2091271B (en) Recombinant dna
WO1999036516A3 (en) Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
AU4965499A (en) Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation
AU3365095A (en) High throughput screening method for sequences or genetic alterations in nucleic acids
ATE79474T1 (de) Verfahren zum in vitro-nachweis und bestimmung unbekannter pathogene oder genetischer einheiten.
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE311443T1 (de) Methoden zur durchforstung (screenen) von proteinen
Okubo et al. Monitoring cell physiology by expression profiles and discovering cell type-specific genes by compiled expression profiles
ATE360688T1 (de) Dna-fragment, dieses enthaltender rekombinanter vektor und verfahren zur expression von fremdgenen unter dessen verwendung
ES2061536T3 (es) Procedimiento para la obtencion de glucosa dehidrogenasa a partir de bacillus megaterium.
DE69632963D1 (de) Mch3, eine apoptosis-protease, kodierende nukleinsäuren und methoden zur verwendung
KR960017845A (ko) 부위-지정 변이유발방법
TW329476B (en) Method for detecting contaminant DNA in a protein product and kits used for the same purpose
EP0904283A4 (de) Menschliches netrin-1
WO2001038359A3 (en) Drosophila nicotinic acetylcholine receptor
WO2002029101A3 (en) Methods for cloning, sequencing and expressing genes from complex microbial populations
KR960705934A (ko) 엔도텔린 전환 효소(Endothelin Converting Enzyme)
Okada et al. Many highly repetitive and transcribable sequences are derived from tRNA genes
EP1182212A3 (de) Ultraspiracle (USP)-Protein von Heliothis virescens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties